ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $53,000 | -20.9% | 148,356 | -2.8% | 0.00% | – |
| Q1 2017 | $67,000 | -10.7% | 152,559 | +0.4% | 0.00% | – |
| Q4 2016 | $75,000 | -1.3% | 151,989 | +0.3% | 0.00% | – |
| Q3 2016 | $76,000 | -49.7% | 151,609 | +0.1% | 0.00% | – |
| Q2 2016 | $151,000 | +96.1% | 151,514 | +33.6% | 0.00% | – |
| Q1 2016 | $77,000 | -43.8% | 113,419 | -0.1% | 0.00% | – |
| Q4 2015 | $137,000 | -45.6% | 113,514 | +0.2% | 0.00% | – |
| Q3 2015 | $252,000 | +6.8% | 113,324 | +11.6% | 0.00% | – |
| Q2 2015 | $236,000 | +69.8% | 101,522 | +56.9% | 0.00% | – |
| Q1 2015 | $139,000 | -6.1% | 64,698 | +0.1% | 0.00% | – |
| Q4 2014 | $148,000 | -14.0% | 64,641 | +0.1% | 0.00% | – |
| Q3 2014 | $172,000 | -29.2% | 64,584 | -1.1% | 0.00% | – |
| Q2 2014 | $243,000 | -72.0% | 65,332 | -11.6% | 0.00% | -100.0% |
| Q1 2014 | $868,000 | +101.4% | 73,870 | +42.8% | 0.00% | – |
| Q4 2013 | $431,000 | -13.6% | 51,738 | -3.9% | 0.00% | – |
| Q3 2013 | $499,000 | -1.0% | 53,840 | +4.7% | 0.00% | – |
| Q2 2013 | $504,000 | – | 51,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,368,500 | $3,134,000 | 0.61% |
| TANG CAPITAL MANAGEMENT LLC | 365,000 | $836,000 | 0.46% |
| Abingworth LLP | 603,740 | $1,352,000 | 0.38% |
| Cheyne Capital Management (UK) LLP | 150,000 | $338,000 | 0.09% |
| Telemetry Investments, L.L.C. | 50,000 | $114,000 | 0.07% |
| Rotella Capital Management, Inc. | 19,473 | $45,000 | 0.04% |
| SABBY MANAGEMENT, LLC | 461,957 | $1,058,000 | 0.03% |
| Nine Chapters Capital Management LLC | 113,700 | $260,000 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 49,471 | $113,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $200,000 | 0.01% |